Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,500,000
Closed -$160M – 1079
2024
Q1
$160M Hold
1,500,000
– – 0.17% 103
2023
Q4
$148M Hold
1,500,000
– – 0.18% 101
2023
Q3
$156M Buy
+1,500,000
New +$167M 0.22% 80

Other funds holding MRNA

DZ Bank's MRNA Position: Q2 2026 in Review

DZ Bank increased its Moderna (MRNA) stake by 29% in Q2 2026, buying an estimated $230K and bringing the position to 19,804 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #703.

DZ Bank first reported a position in MRNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $38.9M in Q4 2021. 787 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • DZ Bank held 19,804 shares of Moderna worth $1.4M as of Q2 2026.
  • DZ Bank bought 4,443 Moderna shares in Q2 2026, an estimated $230K.
  • Moderna made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #703 holding.
  • DZ Bank first reported a position in Moderna in Q1 2021 and has held it in 22 quarters since.
  • DZ Bank's Moderna position peaked at $38.9M in Q4 2021.
  • 787 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.